Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model
mBio · 10.06.2026 · 17 (6)
DOI: 10.1128/mbio.02731-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 10.06.2026. Verfasst von Alexander M Aldejohann und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Würzburg, Institute for Hygiene and Microbiology, Würzburg, Germany. Hauptthemen laut MEDLINE: Ergosterol, Antifungal Agents, Drug Resistance, Multiple, Fungal, Candida glabrata. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Nakaseomyces glabratus (formerly Candida glabrata ) is a leading cause of invasive candidiasis and rapidly develops antifungal drug resistance during treatment. An increasing number of clinical isolates show reduced susceptibility to echinocandins and azoles, leaving amphotericin B (AMB) as a last therapeutic option. Resistance of N. glabratus to this drug is rare, and its underlying mechanisms are still not fully understood. Here, we describe two independent multidrug-resistant bloodstream isolates displaying resistance to AMB and anidulafungin (ANF), as well as a reduced susceptibility to azoles. We performed whole-genome sequencing and sterol profiling on nine clinical N. glabratus isolates, which were resistant to ANF and displayed resistance or low susceptibility to fluconazole (FLU) and AMB. We identified loss-of-function mutations in the genes ERG3 and ERG4 , which could be linked to ergosterol depletion and AMB resistance. The transcriptional response of the reference strain CBS138 and an AMB R + ANF R isolate was analyzed by RNA-seq, revealing that ergosterol depletion also contributed to upregulation of ERG and ABC transporter genes, which might explain the low FLU susceptibility. Surprisingly, the AMB R isolates displayed severe fitness defects, and one of them was fully virulent in a Galleria mellonella infection model. Our results indicate that ergosterol depletion in N. glabratus leads to AMB resistance without affecting fitness or virulence. IMPORTANCE The major human fungal pathogen Nakaseomyces glabratus is well known for its fast development of antifungal drug resistance, especially against commonly used azoles. However, it can also acquire resistance to echinocandins, leading to multidrug resistance (MDR) and leaving amphotericin B (AMB) as the last therapeutic option. AMB resistance is rare, mainly caused by ergosterol depletion, and is normally associated with severe fitness costs for the pathogen. However, we found N. glabratus bloodstream isolates with stable AMB resistance without apparent fitness and virulence defects. The underlying ergosterol depletion contributed to low azole susceptibility and was associated with anidulafungin resistance. These findings demonstrate how fast MDR can evolve in N. glabratus and underline the need for close resistance monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Würzburg, Institute for Hygiene and Microbiology, Würzburg, Germany.
- Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany.
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Department of Pharmacy-Center for Drug Research, Ludwig Maximilians University Munich, Munich, Germany.
- Core Unit Systems Medicine, University of Würzburg, Würzburg, Germany.
- Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Alexander M Aldejohann, Heimo Lagler, Grit Walther, Christina A Cuomo, Ronny Martin
Förderung
- Deutsche Forschungsgemeinschaft
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Aldejohann, A. M., Thielemann, N., Martinez Zurita, A., Müller, C., Gräfenhan, T., Kriz, R., Lagler, H., Behr, I. S., Reus, N., Schöninger, A., Walther, G., Mazan, L. M., Wilhelm, H., Willinger, B., Cuomo, C. A., Kurzai, O., & Martin, R. (2026). Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model. mBio, 17(6). https://doi.org/10.1128/mbio.02731-25
Vancouver
Aldejohann AM, Thielemann N, Martinez Zurita A, Müller C, Gräfenhan T, Kriz R, et al. Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model. mBio. 2026;17(6). doi:10.1128/mbio.02731-25
BibTeX
@article{Aldejohann2026,
author = {Aldejohann, Alexander M and Thielemann, Nadja and Martinez Zurita, Aina and Müller, Christoph and Gräfenhan, Tom and Kriz, Richard and Lagler, Heimo and Behr, Isabell S and Reus, Nathalie and Schöninger, Annika and Walther, Grit and Mazan, Lena-Marie and Wilhelm, Hannah and Willinger, Birgit and Cuomo, Christina A and Kurzai, Oliver and Martin, Ronny},
title = {Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model},
journal = {mBio},
year = {2026},
volume = {17},
number = {6},
doi = {10.1128/mbio.02731-25}
}
EUVIMED